Thymic versus induced regulatory T cells-who regulates the regulators?

Frontiers in Immunology

Volumn 4, Issue JUN, 2013, Pages

  Povoleri, Giovanni Antonio Maria ^a,b   Scottá, Cristiano ^a,b   Nova Lamperti, Estefania Andrea ^a,b   John, Susan ^a,b   Lombardi, Giovanna ^a,b   Afzali, Behdad ^a,b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Epigenetics; Foxp3; Interleukin 17; ITr35; MicroRNA; Regulatory T cells; Th3; Tr1

Indexed keywords

CD28 ANTIGEN; CD5 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GAMMA INTERFERON; HEMAGGLUTININ; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 17; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 2 RECEPTOR BETA; INTERLEUKIN 2 RECEPTOR GAMMA; INTERLEUKIN 4; JANUS KINASE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MAMMALIAN TARGET OF RAPAMYCIN; MICRORNA 155; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE B; RAF PROTEIN; RAPAMYCIN; RAS PROTEIN; STAT5 PROTEIN; T LYMPHOCYTE RECEPTOR; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR FOXP3; TRANSCRIPTION FACTOR NFAT; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1; UNINDEXED DRUG;

AUTOIMMUNE DISEASE; CD4+ T LYMPHOCYTE; CELL DIFFERENTIATION; CELL THERAPY; DEMETHYLATION; DOWN REGULATION; EFFECTOR CELL; ENHANCER REGION; EPIGENETICS; GENE EXPRESSION; GENETIC TRANSCRIPTION; HISTONE ACETYLATION; HUMAN; IMMUNE RESPONSE; INFLAMMATION; MULTICENTER STUDY (TOPIC); MUTATION; NONHUMAN; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); PHENOTYPE; REGULATORY T LYMPHOCYTE; REVIEW; SIGNAL TRANSDUCTION;

EID: 84883751545     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2013.00169     Document Type: Review

References (292)

1. Abbas, A. K., Benoist, C., Bluestone, J. A., Campbell, D. J., Ghosh, S., Hori, S., et al. (2013). Regulatory T cells: recommendations to simplify the nomenclature. Nat. Immunol. 14, 307-308. doi:10.1038/ni.2554
2. Afzali, B., Lombardi, G., Lechler, R. I., and Lord, G. M. (2007). The role of T helper 17 (Th17) and regulatory T cells (Treg) in human organ transplantation and autoimmune disease. Clin. Exp. Immunol. 148, 32-46. doi:10.1111/j.1365-2249.2007.03356.x
3. Afzali, B., Mitchell, P., Lechler, R. I., John, S., and Lombardi, G. (2010). Translational mini-review series on Th17 cells: induction of interleukin-17 production by regulatory T cells. Clin. Exp. Immunol. 159, 120-130. doi:10.1111/j.1365-2249.2009.04038.x
4. Afzali, B., Mitchell, P. J., Edozie, F. C., Povoleri, G., Dowson, S., Demandt, L., et al. (2013). CD161 expression characterizes a sub-population of human regulatory T cells that produces IL-17 in a STAT3 dependent manner. Eur. J. Immunol. Available at: http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1521-4141/accepted [Accessed May 16, 2013] doi:10.1002/eji.201243296
5. Akdis, M., Verhagen, J., Taylor, A., Karamloo, F., Karagiannidis, C., Crameri, R., et al. (2004). Immune responses in healthy and allergic individuals are characterized by a fine balance between allergen-specific T regulatory 1 and T helper 2 cells. J. Exp. Med. 199, 1567-1575. doi:10.1084/jem.20032058
6. Akimova, T., Beier, U. H., Wang, L., Levine, M. H., and Hancock, W. W. (2011). Helios expression is a marker of T cell activation and proliferation. PLoS ONE 6:e24226. doi:10.1371/journal.pone.0024226
7. Annacker, O., Coombes, J. L., Malmstrom, V., Uhlig, H. H., Bourne, T., Johansson-Lindbom, B., et al. (2005). Essential role for CD103 in the T cell-mediated regulation of experimental colitis. J. Exp. Med. 202, 1051-1061. doi:10.1084/jem.20040662
8. Apostolou, I., and von Boehmer, H. (2004). In vivo instruction of suppressor commitment in naive T cells. J. Exp. Med. 199, 1401-1408. doi:10.1084/jem.20040249
9. Asano, M., Toda, M., Sakaguchi, N., and Sakaguchi, S. (1996). Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation. J. Exp. Med. 184, 387-396. doi:10.1084/jem.184.2.387
10. Aschenbrenner, K., D'Cruz, L. M., Vollmann, E. H., Hinterberger, M., Emmerich, J., Swee, L. K., et al. (2007). Selection of Foxp3+ regulatory T cells specific for self antigen expressed and presented by Aire+ medullary thymic epithelial cells. Nat. Immunol. 8, 351-358. doi:10.1038/ni1444
11. Asseman, C., Mauze, S., Leach, M. W., Coffman, R. L., and Powrie, F. (1999). An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation. J. Exp. Med. 190, 995-1004. doi:10.1084/jem.190.7.995
12. Ayyoub, M., Deknuydt, F., Raimbaud, I., Dousset, C., Leveque, L., Bioley, G., et al. (2009). Human memory FOXP3+ Tregs secrete IL-17 ex vivo and constitutively express the T(H)17 lineage-specific transcription factor RORgamma t. Proc. Natl. Acad. Sci. U.S.A. 106, 8635-8640. doi:10.1073/pnas.0900621106
13. Babiarz, J. E., Ruby, J. G., Wang, Y., Bartel, D. P., and Blelloch, R. (2008). Mouse ES cells express endogenous shRNAs, siRNAs, and other microprocessor-independent, dicer-dependent small RNAs. Genes Dev. 22, 2773-2785. doi:10.1101/gad.1705308
14. Bacchetta, R., Passerini, L., Gambineri, E., Dai, M., Allan, S. E., Perroni, L., et al. (2006). Defective regulatory and effector T cell functions in patients with FOXP3 mutations. J. Clin. Invest. 116, 1713-1722. doi:10.1172/JCI25112
15. Baecher-Allan, C., Brown, J. A., Freeman, G. J., and Hafler, D. A. (2001). CD4+CD25 high regulatory cells in human peripheral blood. J. Immunol. 167, 1245-1253.
16. Baecher-Allan, C., and Hafler, D. A. (2006). Human regulatory T cells and their role in autoimmune disease. Immunol. Rev. 212, 203-216. doi:10.1111/j.0105-2896.2006.00417.x
17. Baltimore, D., Boldin, M. P., O'Connell, R. M., Rao, D. S., and Taganov, K. D. (2008). MicroRNAs: new regulators of immune cell development and function. Nat. Immunol. 9, 839-845. doi:10.1038/ni.f.209
18. Barnes, M. J., Krebs, P., Harris, N., Eidenschenk, C., Gonzalez-Quintial, R., Arnold, C. N., et al. (2009). Commitment to the regulatory T cell lineage requires CARMA1 in the thymus but not in the periphery. PLoS Biol. 7:e51. doi:10.1371/journal.pbio.1000051
19. Baron, U., Floess, S., Wieczorek, G., Baumann, K., Grützkau, A., Dong, J., et al. (2007). DNA demethylation in the human FOXP3 locus discriminates regulatory T cells from activated FOXP3(+) conventional T cells. Eur. J. Immunol. 37, 2378-2389. doi:10.1002/eji.200737594
20. Bartel, D. P. (2009). MicroRNAs: target recognition and regulatory functions. Cell 136, 215-233. doi:10.1016/j.cell.2009.01.002
21. Battaglia, M., Stabilini, A., Migliavacca, B., Horejs-Hoeck, J., Kaupper, T., and Roncarolo, M. G. (2006). Rapamycin promotes expansion of functional CD4+CD25+FOXP3+ regulatory T cells of both healthy subjects and type 1 diabetic patients. J. Immunol. 177, 8338-8347.
22. Belkaid, Y. (2007). Regulatory T cells and infection: a dangerous necessity. Nat. Rev. Immunol. 7, 875-888. doi:10.1038/nri2189
23. Belkaid, Y., Piccirillo, C. A., Mendez, S., Shevach, E. M., and Sacks, D. L. (2002). CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity. Nature 420, 502-507. doi:10.1038/nature01152
24. Bennett, C. L., Christie, J., Ramsdell, F., Brunkow, M. E., Ferguson, P. J., Whitesell, L., et al. (2001). The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat. Genet. 27, 20-21. doi:10.1038/83713
25. Bensinger, S. J., Bandeira, A., Jordan, M. S., Caton, A. J., and Laufer, T. M. (2001). Major histocompatibility complex class II-positive cortical epithelium mediates the selection of CD4(+)25(+) immunoregulatory T cells. J. Exp. Med. 194, 427-438. doi:10.1084/jem.194.4.427
26. Benson, M. J., Pino-Lagos, K., Rosemblatt, M., and Noelle, R. J. (2007). All-trans retinoic acid mediates enhanced T reg cell growth, differentiation, and gut homing in the face of high levels of co-stimulation. J. Exp. Med. 204, 1765-1774. doi:10.1084/jem.20070719
27. Beriou, G., Costantino, C. M., Ashley, C. W., Yang, L., Kuchroo, V. K., Baecher-Allan, C., et al. (2009). IL-17-producing human peripheral regulatory T cells retain suppressive function. Blood 113, 4240-4249. doi:10.1182/blood-2008-10-183251
28. Bettelli, E., Carrier, Y., Gao, W., Korn, T., Strom, T. B., Oukka, M., et al. (2006). Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441, 235-238. doi:10.1038/nature04753
29. Bettelli, E., Dastrange, M., and Oukka, M. (2005). Foxp3 interacts with nuclear factor of activated T cells and NF-kappa B to repress cytokine gene expression and effector functions of T helper cells. Proc. Natl. Acad. Sci. U.S.A. 102, 5138-5143. doi:10.1073/pnas.0501675102
30. Bettini, M., Castellaw, A. H., Lennon, G. P., Burton, A. R., and Vignali, D. A. A. (2012). Prevention of autoimmune diabetes by ectopic pancreatic-cell expression of interleukin-35. Diabetes 61, 1519-1526. doi:10.2337/db11-0784
31. Blair, P. J., Bultman, S. J., Haas, J. C., Rouse, B. T., Wilkinson, J. E., and Godfrey, V. L. (1994). CD4+CD8-T cells are the effector cells in disease pathogenesis in the scurfy (sf) mouse. J. Immunol. 153, 3764-3774.
32. Blazar, B. R., Murphy, W. J., and Abedi, M. (2012). Advances in graft-versus-host disease biology and therapy. Nat. Rev. Immunol. 12, 443-458. doi:10.1038/nri3212
33. Boks, M. A., Kager-Groenland, J. R., Haasjes, M. S. P., Zwaginga, J. J., van Ham, S. M., and ten Brinke, A. (2012). IL-10-generated tolerogenic dendritic cells are optimal for functional regulatory T cell induction-a comparative study of human clinical-applicable DC. Clin. Immunol. 142, 332-342. doi:10.1016/j.clim.2011.11.011
34. Bopp, T., Becker, C., Klein, M., Klein-Hessling, S., Palmetshofer, A., Serfling, E., et al. (2007). Cyclic adenosine monophosphate is a key component of regulatory T cell-mediated suppression. J. Exp. Med. 204, 1303-1310. doi:10.1084/jem.20062129
35. Bruder, D., Probst-Kepper, M., Westendorf, A. M., Geffers, R., Beissert, S., Loser, K., et al. (2004). Neuropilin-1: a surface marker of regulatory T cells. Eur. J. Immunol. 34, 623-630. doi:10.1002/eji.200324799
36. Brun, V., Bastian, H., Neveu, V., and Foussat, A. (2009). Clinical grade production of IL-10 producing regulatory Tr1 lymphocytes for cell therapy of chronic inflammatory diseases. Int. Immunopharmacol. 9, 609-613. doi:10.1016/j.intimp.2009.01.032
37. Brunkow, M. E., Jeffery, E. W., Hjerrild, K. A., Paeper, B., Clark, L. B., Yasayko, S. A., et al. (2001). Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat. Genet. 27, 68-73. doi:10.1038/83784
38. Brüstle, A., Heink, S., Huber, M., Rosenplänter, C., Stadelmann, C., Yu, P., et al. (2007). The development of inflammatory T(H)-17 cells requires interferon-regulatory factor 4. Nat. Immunol. 8, 958-966. doi:10.1038/ni1500
39. Burchill, M. A., Yang, J., Vang, K. B., Moon, J. J., Chu, H. H., Lio, C.-W. J., et al. (2008). Linked T cell receptor and cytokine signaling govern the development of the regulatory T cell repertoire. Immunity 28, 112-121. doi:10.1016/j.immuni.2007.11.022
40. Burchill, M. A., Yang, J., Vogtenhuber, C., Blazar, B. R., and Farrar, M. A. (2007). IL-2 receptor beta-dependent STAT5 activation is required for the development of Foxp3+ regulatory T cells. J. Immunol. 178, 280-290.
41. Bushell, A., Jones, E., Gallimore, A., and Wood, K. (2005). The generation of CD25+ CD4+ regulatory T cells that prevent allograft rejection does not compromise immunity to a viral pathogen. J. Immunol. 174, 3290-3297.
42. Cao, X., Cai, S. F., Fehniger, T. A., Song, J., Collins, L. I., Piwnica-Worms, D. R., et al. (2007). Granzyme B and perforin are important for regulatory T cell-mediated suppression of tumor clearance. Immunity 27, 635-646. doi:10.1016/j.immuni.2007.08.014
43. Cardone, J., Le Friec, G., Vantourout, P., Roberts, A., Fuchs, A., Jackson, I., et al. (2010). Complement regulator CD46 temporally regulates cytokine production by conventional and unconventional T cells. Nat. Immunol. 11, 862-871. doi:10.1038/ni.1917
44. Cedar, H., and Bergman, Y. (2011). Epigenetics of haematopoietic cell development. Nat. Rev. Immunol. 11, 478-488. doi:10.1038/nri2991
45. Chatila, T. A., Blaeser, F., Ho, N., Lederman, H. M., Voulgaropoulos, C., Helms, C., et al. (2000). JM2, encoding a fork head-related protein, is mutated in X-linked autoimmunity-allergic disregulation syndrome. J. Clin. Invest. 106, R75-R81. doi:10.1172/JCI11679
46. Chaturvedi, V., Collison, L. W., Guy, C. S., Workman, C. J., and Vignali, D. A. (2011). Cutting edge: human regulatory T cells require IL-35 to mediate suppression and infectious tolerance. J. Immunol. 186, 6661-6666. doi:10.4049/jimmunol.1100315
47. Chaudhry, A., Rudra, D., Treuting, P., Samstein, R. M., Liang, Y., Kas, A., et al. (2009). CD4+ regulatory T cells control TH17 responses in a Stat3-dependent manner. Sci. Signal. 326, 986. doi:10.1038/nrg1990
48. Chen, K., and Rajewsky, N. (2007). The evolution of gene regulation by transcription factors and microRNAs. Nat. Rev. Genet. 8, 93-103. doi:10.1038/nrg1990
49. Chen, W., Jin, W., Hardegen, N., Lei, K.-J., Li, L., Marinos, N., et al. (2003). Conversion of peripheral CD4+CD25-naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J. Exp. Med. 198, 1875-1886. doi:10.1084/jem.20030152
50. Chen, W., Jin, W., and Wahl, S. M. (1998). Engagement of cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) induces transforming growth factor beta (TGF-beta) production by murine CD4(+) T cells. J. Exp. Med. 188, 1849-1857. doi:10.1084/jem.188.10.1849
51. Chen, X., Priatel, J. J., Chow, M. T., and Teh, H.-S. (2008). Preferential development of CD4 and CD8 T regulatory cells in RasGRP1-deficient mice. J. Immunol. 180, 5973-5982.
52. Chen, Y., Kuchroo, V. K., Inobe, J., Hafler, D. A., and Weiner, H. L. (1994). Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science 265, 1237-1240. doi:10.1126/science.7520605
53. Chendrimada, T. P., Finn, K. J., Ji, X., Baillat, D., Gregory, R. I., Liebhaber, S. A., et al. (2007). MicroRNA silencing through RISC recruitment of eIF6. Nature 447, 823-828. doi:10.1038/nature05841
54. Cheng, G., Yu, A., Dee, M. J., and Malek, T. R. (2013). IL-2R signaling is essential for functional maturation of regulatory T cells during thymic development. J. Immunol. 190, 1567-1575. doi:10.4049/jimmunol.1201218
55. Chiang, Y. J., Kole, H. K., Brown, K., Naramura, M., Fukuhara, S., Hu, R. J., et al. (2000). Cbl-b regulates the CD28 dependence of T-cell activation. Nature 403, 216-220. doi:10.1038/35003235
56. Chong, M. M. W., Rasmussen, J. P., Rudensky, A. Y., Rundensky, A. Y., and Littman, D. R. (2008). The RNAseIII enzyme Drosha is critical in T cells for preventing lethal inflammatory disease. J. Exp. Med. 205, 2005-2017. doi:10.1084/jem.20081219
57. Ciubotariu, R., Colovai, A. I., Pennesi, G., Liu, Z., Smith, D., Berlocco, P., et al. (1998). Specific suppression of human CD4+ Th cell responses to pig MHC antigens by CD8+CD28-regulatory T cells. J. Immunol. 161, 5193-5202.
58. Cobb, B. S., Hertweck, A., Smith, J., O'Connor, E., Graf, D., Cook, T., et al. (2006). A role for Dicer in immune regulation. J. Exp. Med. 203, 2519-2527. doi:10.1084/jem.20061692
59. Collison, L. W., Chaturvedi, V., Henderson, A. L., Giacomin, P. R., Guy, C., Bankoti, J., et al. (2010). IL-35-mediated induction of a potent regulatory T cell population. Nat. Immunol. 11, 1093-1101. doi:10.1038/ni.1952
60. Collison, L. W., Pillai, M. R., Chaturvedi, V., and Vignali, D. A. A. (2009). Regulatory T cell suppression is potentiated by target T cells in a cell contact, IL-35-and IL-10-dependent manner. J. Immunol. 182, 6121-6128. doi:10.4049/jimmunol.0803646
61. Collison, L. W., Workman, C. J., Kuo, T. T., Boyd, K., Wang, Y., Vignali, K. M., et al. (2007). The inhibitory cytokine IL-35 contributes to regulatory T-cell function. Nature 450, 566-569. doi:10.1038/nature06306
62. Constant, S. L., and Bottomly, K. (1997). Induction of Th1 and Th2 CD4+ T cell responses: the alternative approaches. Annu. Rev. Immunol. 15, 297-322. doi:10.1146/annurev.immunol.15.1.297
63. Coombes, J. L., Siddiqui, K. R. R., Arancibia-Cárcamo, C. V., Hall, J., Sun, C.-M., Belkaid, Y., et al. (2007). A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-beta and retinoic acid-dependent mechanism. J. Exp. Med. 204, 1757-1764. doi:10.1084/jem.20070590
64. Curotto de Lafaille, M. A., Kutchukhidze, N., Shen, S., Ding, Y., Yee, H., and Lafaille, J. J. (2008). Adaptive Foxp3+ regulatory T cell-dependent and -independent control of allergic inflammation. Immunity 29, 114-126. doi:10.1016/j.immuni.2008.05.010
65. De Jong, E., Suddason, T., and Lord, G. (2010). Translational mini review series on Th17 cells: development of mouse and human T helper 17 cells. Clin. Exp. Immunol. 159, 148-158. doi:10.1111/j.1365-2249.2009.04041.x
66. Deaglio, S., Dwyer, K. M., Gao, W., Friedman, D., Usheva, A., Erat, A., et al. (2007). Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression. J. Exp. Med. 204, 1257-1265. doi:10.1084/jem.20062512
67. Desreumaux, P., Foussat, A., Allez, M., Beaugerie, L., Hébuterne, X., Bouhnik, Y., et al. (2012). Safety and efficacy of antigen-specific regulatory T-cell therapy for patients with refractory Crohn's disease. Gastroenterology 143, 1207.e1-2-12017.e1-2. doi:10.1053/j.gastro.2012.07.116
68. Dhodapkar, M. V., Steinman, R. M., Krasovsky, J., Munz, C., and Bhardwaj, N. (2001). Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells. J. Exp. Med. 193, 233-238. doi:10.1084/jem.193.2.233
69. Di Ianni, M., Falzetti, F., Carotti, A., Terenzi, A., Castellino, F., Bonifacio, E., et al. (2011). Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation. Blood 117, 3921-3928. doi:10.1182/blood-2010-10-311894
70. DiPaolo, R. J., Brinster, C., Davidson, T. S., Andersson, J., Glass, D., and Shevach, E. M. (2007). Autoantigen-specific TGFbeta-induced Foxp3+ regulatory T cells prevent autoimmunity by inhibiting dendritic cells from activating autoreactive T cells. J. Immunol. 179, 4685-4693.
71. E, X. Q., Meng, H. X., Cao, Y., Zhang, S. Q., Bi, Z. G., and Yamakawa, M. (2012). Distribution of regulatory T cells and interaction with dendritic cells in the synovium of rheumatoid arthritis. Scand. J. Rheumatol. 41, 413-420. doi:10.3109/03009742.2012.696135
72. Elias, K. M., Laurence, A., Davidson, T. S., Stephens, G., Kanno, Y., Shevach, E. M., et al. (2007). Retinoic acid inhibits Th17 polarization and enhances FoxP3 expression through a Stat-3/Stat-5 independent signaling pathway. Blood 111, 1013-1020. doi:10.1182/blood-2007-06-096438
73. Fayyad-Kazan, H., Rouas, R., Merimi, M., Zein El, N., Lewalle, P., Jebbawi, F., et al. (2010). Valproate treatment of human cord blood CD4-positive effector T cells confers on them the molecular profile (microRNA signature and FOXP3 expression) of natural regulatory CD4-positive cells through inhibition of histone deacetylase. J. Biol. Chem. 285, 20481-20491. doi:10.1074/jbc. M110.119628
74. Feng, T., Cao, A. T., Weaver, C. T., Elson, C. O., and Cong, Y. (2011). Interleukin-12 converts Foxp3+ regulatory T cells to interferon-γ-producing Foxp3+ T cells that inhibit colitis. Gastroenterology 140, 2031-2043. doi:10.1053/j.gastro.2011.03.009
75. Ferrara, N., Gerber, H.-P., and LeCouter, J. (2003). The biology of VEGF and its receptors. Nat. Med. 9, 669-676. doi:10.1038/nm0603-669
76. Floess, S., Freyer, J., Siewert, C., Baron, U., Olek, S., Polansky, J., et al. (2007). Epigenetic control of the foxp3 locus in regulatory T cells. PLoS Biol. 5:e38. doi:10.1371/journal.pbio.0050038
77. Fontenot, J. D., Dooley, J. L., Farr, A. G., and Rudensky, A. Y. (2005a). Developmental regulation of Foxp3 expression during ontogeny. J. Exp. Med. 202, 901-906. doi:10.1084/jem.20050784
78. Fontenot, J. D., Rasmussen, J. P., Gavin, M. A., and Rudensky, A. Y. (2005b). A function for interleukin 2 in Foxp3-expressing regulatory T cells. Nat. Immunol. 6, 1142-1151. doi:10.1038/ni1263
79. Fontenot, J. D., Rasmussen, J. P., Williams, L. M., Dooley, J. L., Farr, A. G., and Rudensky, A. Y. (2005c). Regulatory T cell lineage specification by the forkhead transcription factor foxp3. Immunity 22, 329-341. doi:10.1016/j.immuni.2005.01.016
80. Fontenot, J. D., Gavin, M. A., and Rudensky, A. Y. (2003). Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat. Immunol. 4, 330-336. doi:10.1038/ni904
81. Gagliani, N., Magnani, C. F., Huber, S., Gianolini, M. E., Pala, M., Licona-Limon, P., et al. (2013). Coexpression of CD49b and LAG-3 identifies human and mouse T regulatory type 1 cells. Nat. Med. 19, 739-746. doi:10.1038/nm.3179
82. Gaidot, A., Landau, D. A., Martin, G. H., Bonduelle, O., Grinberg-Bleyer, Y., Matheoud, D., et al. (2011). Immune reconstitution is preserved in hematopoietic stem cell transplantation coadministered with regulatory T cells for GVHD prevention. Blood 117, 2975-2983. doi:10.1182/blood-2010-08-299974
83. Gavin, M. A., Rasmussen, J. P., Fontenot, J. D., Vasta, V., Manganiello, V. C., Beavo, J. A., et al. (2007). Foxp3-dependent programme of regulatory T-cell differentiation. Nature 445, 771-775. doi:10.1038/nature05543
84. Gavin, M. A., Torgerson, T. R., Houston, E., DeRoos, P., Ho, W. Y., Stray-Pedersen, A., et al. (2006). Single-cell analysis of normal and FOXP3-mutant human T cells: FOXP3 expression without regulatory T cell development. Proc. Natl. Acad. Sci. U.S.A. 103, 6659-6664. doi:10.1073/pnas.0509484103
85. Gilliet, M., and Liu, Y.-J. (2002). Generation of human CD8 T regulatory cells by CD40 ligand-activated plasmacytoid dendritic cells. J. Exp. Med. 195, 695-704. doi:10.1084/jem.20011603
86. Glinka, Y., and Prud'Homme, G. J. (2008). Neuropilin-1 is a receptor for transforming growth factor beta-1, activates its latent form, and promotes regulatory T cell activity. J. Leukoc. Biol. 84, 302-310. doi:10.1189/jlb.0208090
87. Golovina, T. N., Mikheeva, T., Brusko, T. M., Blazar, B. R., Bluestone, J. A., and Riley, J. L. (2011). Retinoic acid and rapamycin differentially affect and synergistically promote the ex vivo expansion of natural human T regulatory cells. PLoS ONE 6:e15868. doi:10.1371/journal.pone.0015868
88. Gondek, D. C., Lu, L.-F., Quezada, S. A., Sakaguchi, S., and Noelle, R. J. (2005). Cutting edge: contact-mediated suppression by CD4+CD25+ regulatory cells involves a granzyme B-dependent, perforin-independent mechanism. J. Immunol. 174, 1783-1786.
89. Gregori, S., Tomasoni, D., Pacciani, V., Scirpoli, M., Battaglia, M., Magnani, C. F., et al. (2010). Differentiation of type 1 T regulatory cells (Tr1) by tolerogenic DC-10 requires the IL-10-dependent ILT4/HLA-G pathway. Blood 116, 935-944. doi:10.1182/blood-2009-07-234872
90. Grigoriadis, G., Vasanthakumar, A., Banerjee, A., Grumont, R., Overall, S., Gleeson, P., et al. (2011). c-Rel controls multiple discrete steps in the thymic development of Foxp3+ CD4 regulatory T cells. PLoS ONE 6:e26851. doi:10.1371/journal.pone.0026851
91. Groux, H., O'Garra, A., Bigler, M., Rouleau, M., Antonenko, S., de Vries, J. E., et al. (1997). A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 389, 737-742. doi:10.1038/39614
92. Hamano, K., Rawsthorne, M. A., Bushell, A. R., Morris, P. J., and Wood, K. J. (1996). Evidence that the continued presence of the organ graft and not peripheral donor microchimerism is essential for maintenance of tolerance to alloantigen in vivo in anti-CD4 treated recipients. Transplantation 62, 856-860. doi:10.1097/00007890-199609270-00026
93. Han, J., Lee, Y., Yeom, K.-H., Nam, J.-W., Heo, I., Rhee, J.-K., et al. (2006). Molecular basis for the recognition of primary microRNAs by the Drosha-DGCR8 complex. Cell 125, 887-901. doi:10.1016/j.cell.2006.03.043
94. Hansen, W., Hutzler, M., Abel, S., Alter, C., Stockmann, C., Kliche, S., et al. (2012). Neuropilin 1 deficiency on CD4+Foxp3+ regulatory T cells impairs mouse melanoma growth. J. Exp. Med. 209, 2001-2016. doi:10.1084/jem.20111497
95. Harada, Y., Harada, Y., Elly, C., Ying, G., Paik, J.-H., DePinho, R. A., et al. (2010). Transcription factors Foxo3a and Foxo1 couple the E3 ligase Cbl-b to the induction of Foxp3 expression in induced regulatory T cells. J. Exp. Med. 207, 1381-1391. doi:10.1084/jem.20100004
96. Haxhinasto, S., Mathis, D., and Benoist, C. (2008). The AKT-mTOR axis regulates de novo differentiation of CD4+Foxp3+ cells. J. Exp. Med. 205, 565-574. doi:10.1084/jem.20071477
97. Hill, J. A., Feuerer, M., Tash, K., Haxhinasto, S., Perez, J., Melamed, R., et al. (2007). Foxp3 transcription-factor-dependent and-independent regulation of the regulatory T cell transcriptional signature. Immunity 27, 786-800. doi:10.1016/j.immuni.2007.09.010
98. Hill, J. A., Hall, J. A., Sun, C.-M., Cai, Q., Ghyselinck, N., Chambon, P., et al. (2008). Retinoic acid enhances Foxp3 induction indirectly by relieving inhibition from CD4+CD44hi cells. Immunity 29, 758-770. doi:10.1016/j.immuni
99. Hippen, K. L., Riley, J. L., June, C. H., and Blazar, B. R. (2011). Clinical perspectives for regulatory T cells in transplantation tolerance. Semin. Immunol. 23, 462-468. doi:10.1016/j.smim.2011.07.008
100. Hirahara, K., Vahedi, G., Ghoreschi, K., Yang, X.-P., Nakayamada, S., Kanno, Y., et al. (2011). Helper T-cell differentiation and plasticity: insights from epigenetics. Immunology 134, 235-245. doi:10.1111/j.1365-2567.2011.03483.x
101. Hori, S. (2010). Developmental plasticity of Foxp3+ regulatory T cells. Curr. Opin. Immunol. 22, 575-582. doi:10.1016/j.coi
102. Hori, S. (2011). Regulatory T cell plasticity: beyond the controversies. Trends Immunol. 32, 295-300. doi:10.1016/j.it.2011.04.004
103. Hori, S., Nomura, T., and Sakaguchi, S. (2003). Control of regulatory T cell development by the transcription factor Foxp3. Science 299, 1057-1061. doi:10.1126/science.1079490
104. Hsieh, C.-S., Liang, Y., Tyznik, A. J., Self, S. G., Liggitt, D., and Rudensky, A. Y. (2004). Recognition of the peripheral self by naturally arising CD25+ CD4+ T cell receptors. Immunity 21, 267-277. doi:10.1016/j.immuni.2004.07.009
105. Hsieh, C.-S., Zheng, Y., Liang, Y., Fontenot, J. D., and Rudensky, A. Y. (2006). An intersection between the self-reactive regulatory and nonregulatory T cell receptor repertoires. Nat. Immunol. 7, 401-410. doi:10.1038/ni1318
106. Huang, C.-T., Workman, C. J., Flies, D., Pan, X., Marson, A. L., Zhou, G., et al. (2004). Role of LAG-3 in regulatory T cells. Immunity 21, 503-513. doi:10.1016/j.immuni.2004.08.010
107. Inobe, J.-I., Slavin, A. J., Komagata, Y., Chen, Y., Liu, L., and Weiner, H. L. (1998). IL-4 is a differentiation factor for transforming growth factor-β secreting Th3 cells and oral administration of IL-4 enhances oral tolerance in experimental allergic encephalomyelitis. Eur. J. Immunol. 28, 2780-2790. doi:10.1002/(SICI)1521-4141(199809)28:09<2780::AID-IMMU2780>3.0.CO;2-J
108. Ishikawa, H., Tanaka, K., Maeda, Y., Aiba, Y., Hata, A., Tsuji, N. M., et al. (2008). Effect of intestinal microbiota on the induction of regulatory CD25+ CD4+ T cells. Clin. Exp. Immunol. 153, 127-135. doi:10.1111/j.1365-2249
109. Isomura, I., Palmer, S., Grumont, R. J., Bunting, K., Hoyne, G., Wilkinson, N., et al. (2009). c-Rel is required for the development of thymic Foxp3+ CD4 regulatory T cells. J. Exp. Med. 206, 3001-3014. doi:10.1084/jem.20091411
110. Issa, F., Chandrasekharan, D., and Wood, K. J. (2011). Regulatory T cells as modulators of chronic allograft dysfunction. Curr. Opin. Immunol. 23, 648-654. doi:10.1016/j.coi.2011.06.005
111. Ivanov, I. I., Frutos, R., de, L., Manel, N., Yoshinaga, K., Rifkin, D. B., et al. (2008). Specific microbiota direct the differentiation of IL-17-producing T-helper cells in the mucosa of the small intestine. Cell Host Microbe 4, 337-349. doi:10.1016/j.chom.2008.09.009
112. Ivanov, I. I., McKenzie, B. S., Zhou, L., Tadokoro, C. E., Lepelley, A., Lafaille, J. J., et al. (2006). The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell 126, 1121-1133. doi:10.1016/j.cell.2006.07.035
113. Izcue, A., Coombes, J. L., and Powrie, F. (2006). Regulatory T cells suppress systemic and mucosal immune activation to control intestinal inflammation. Immunol. Rev. 212, 256-271. doi:10.1111/j.0105-2896.2006.00423.x
114. Janson, P. C. J., Winerdal, M. E., Marits, P., Thörn, M., Ohlsson, R., and Winqvist, O. (2008). FOXP3 promoter demethylation reveals the committed Treg population in humans. PLoS ONE 3:e1612. doi:10.1371/journal.pone.0001612
115. Jeker, L. T., Zhou, X., Blelloch, R., and Bluestone, J. A. (2013). DGCR8-mediated production of canonical micrornas is critical for regulatory T cell function and stability. PLoS ONE 8:e66282. doi:10.1371/journal.pone.0066282
116. Jeker, L. T., Zhou, X., Gershberg, K., de Kouchkovsky, D., Morar, M. M., Stadthagen, G., et al. (2012). MicroRNA 10a marks regulatory T cells. PLoS ONE 7:e36684. doi:10.1371/journal.pone.0036684
117. Jiang, S., Tugulea, S., Pennesi, G., Liu, Z., Mulder, A., Lederman, S., et al. (1998). Induction of MHC-class I restricted human suppressor T cells by peptide priming in vitro. Hum. Immunol. 59, 690-699. doi:10.1016/S0198-8859(98)00073-1
118. Johansson-Lindbom, B., Svensson, M., Pabst, O., Palmqvist, C., Marquez, G., Förster, R., et al. (2005). Functional specialization of gut CD103+ dendritic cells in the regulation of tissue-selective T cell homing. J. Exp. Med. 202, 1063-1073. doi:10.1084/jem.20051100
119. Jonuleit, H., Schmitt, E., Schuler, G., Knop, J., and Enk, A. H. (2000). Induction of interleukin 10-producing, nonproliferating CD4(+) T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells. J. Exp. Med. 192, 1213-1222. doi:10.1084/jem.192.9.1213
120. Jordan, M. S., Boesteanu, A., Reed, A. J., Petrone, A. L., Holenbeck, A. E., Lerman, M. A., et al. (2001). Thymic selection of CD4+CD25+ regulatory T cells induced by an agonist self-peptide. Nat. Immunol. 2, 301-306. doi:10.1038/86302
121. Josefowicz, S. Z., Lu, L.-F., and Rudensky, A. Y. (2012). Regulatory T cells: mechanisms of differentiation and function. Annu. Rev. Immunol. 30, 531-564. doi:10.1146/annurev.immunol.25.022106.141623
122. Josefowicz, S. Z., and Rudensky, A. (2009). Control of regulatory T cell lineage commitment and maintenance. Immunity 30, 616-625. doi:10.1016/j.immuni.2009.04.009
123. Josefowicz, S. Z., Wilson, C. B., and Rudensky, A. Y. (2009). Cutting edge: TCR stimulation is sufficient for induction of Foxp3 expression in the absence of DNA methyltransferase 1. J. Immunol. 182, 6648-6652. doi:10.4049/jimmunol.0803320
124. Kanangat, S., Blair, P., Reddy, R., Daheshia, M., Godfrey, V., Rouse, B. T., et al. (1996). Disease in the scurfy (sf) mouse is associated with overexpression of cytokine genes. Eur. J. Immunol. 26, 161-165. doi:10.1002/eji.1830260125
125. Kemper, C., Chan, A. C., Green, J. M., Brett, K. A., Murphy, K. M., and Atkinson, J. P. (2003). Activation of human CD4+ cells with CD3 and CD46 induces a T-regulatory cell 1 phenotype. Nature 421, 388-392. doi:10.1038/nature01315
126. Khattri, R., Cox, T., Yasayko, S.-A., and Ramsdell, F. (2003). An essential role for Scurfin in CD4+CD25+ T regulatory cells. Nat. Immunol. 4, 337-342. doi:10.1038/ni909
127. Kim, H.-P., and Leonard, W. J. (2007). CREB/ATF-dependent T cell receptor-induced FoxP3 gene expression: a role for DNA methylation. J. Exp. Med. 204, 1543-1551.
128. Kim, J. M., and Rudensky, A. (2006). The role of the transcription factor Foxp3 in the development of regulatory T cells. Immunol. Rev. 212, 86-98. doi:10.1111/j.0105-2896.2006.00426.x
129. Koch, M. A., Tucker-Heard, G., Perdue, N. R., Killebrew, J. R., Urdahl, K. B., and Campbell, D. J. (2009). The transcription factor T-bet controls regulatory T cell homeostasis and function during type 1 inflammation. Nat. Immunol. 10, 595-602. doi:10.1038/ni.1731
130. Koenen, H. J. P. M., Smeets, R. L., Vink, P. M., van Rijssen, E., Boots, A. M. H., and Joosten, I. (2008). Human CD25highFoxp3pos regulatory T cells differentiate into IL-17-producing cells. Blood 112, 2340-2352. doi:10.1182/blood-2008-01-133967
131. Kojima, A., Taguchi, O., and Nishizuka, Y. (1980). Experimental production of possible autoimmune castritis followed by macrocytic anemia in athymic nude mice. Lab. Invest. 42, 387-395.
132. Kojima, A., Tanaka-Kojima, Y., Sakakura, T., and Nishizuka, Y. (1976). Spontaneous development of autoimmune thyroiditis in neonatally thymectomized mice. Lab. Invest. 34, 550-557.
133. Kretschmer, K., Apostolou, I., Hawiger, D., Khazaie, K., Nussenzweig, M. C., and Boehmer von, H. (2005). Inducing and expanding regulatory T cell populations by foreign antigen. Nat. Immunol. 6, 1219-1227. doi:10.1038/ni1265
134. Kwan, W.-H., van der Touw, W., Paz-Artal, E., Li, M. O., and Heeger, P. S. (2013). Signaling through C5a receptor and C3a receptor diminishes function of murine natural regulatory T cells. J. Exp. Med. 210, 257-268. doi:10.1084/jem.20121525
135. Lathrop, S. K., Santacruz, N. A., Pham, D., Luo, J., and Hsieh, C.-S. (2008). Antigen-specific peripheral shaping of the natural regulatory T cell population. J. Exp. Med. 205, 3105-3117. doi:10.1084/jem.20081359
136. Laurence, A., Tato, C. M., Davidson, T. S., Kanno, Y., Chen, Z., Yao, Z., et al. (2007). Interleukin-2 signaling via STAT5 constrains T helper 17 cell generation. Immunity 26, 371-381. doi:10.1016/j.immuni.2007.02.009
137. Le Friec, G., Sheppard, D., Whiteman, P., Karsten, C. M., Shamoun, S. A.-T., Laing, A., et al. (2012). The CD46-Jagged1 interaction is critical for human TH1 immunity. Nat. Immunol. 13, 1213-1221. doi:10.1038/ni.2454
138. Lee, Y., Kim, M., Han, J., Yeom, K.-H., Lee, S., Baek, S. H., et al. (2004). MicroRNA genes are transcribed by RNA polymerase II. EMBO J. 23, 4051-4060. doi:10.1038/sj.emboj.7600385
139. Levings, M. K., Sangregorio, R., Galbiati, F., Squadrone, S., de Waal-Malefyt, R., and Roncarolo, M. G. (2001). IFN-alpha and IL-10 induce the differentiation of human type 1 T regulatory cells. J. Immunol. 166, 5530-5539.
140. Li, J., Liu, Z., Jiang, S., Cortesini, R., Lederman, S., and Suciu-Foca, N. (1999). T suppressor lymphocytes inhibit NF-kappa B-mediated transcription of CD86 gene in APC. J. Immunol. 163, 6386-6392.
141. Li, M. O., Sanjabi, S., and Flavell, R. A. (2006). Transforming growth factor-beta controls development, homeostasis, and tolerance of T cells by regulatory T cell-dependent and -independent mechanisms. Immunity 25, 455-471. doi:10.1016/j.immuni.2006.07.011
142. Lio, C.-W. J., and Hsieh, C.-S. (2008). A two-step process for thymic regulatory T cell development. Immunity 28, 100-111. doi:10.1016/j.immuni.2007.11.021
143. Liston, A., Lu, L.-F., O'Carroll, D., Tarakhovsky, A., and Rudensky, A. Y. (2008a). Dicer-dependent microRNA pathway safeguards regulatory T cell function. J. Exp. Med. 205, 1993-2004. doi:10.1084/jem.20081062
144. Liston, A., Nutsch, K. M., Farr, A. G., Lund, J. M., Rasmussen, J. P., Koni, P. A., et al. (2008b). Differentiation of regulatory Foxp3+ T cells in the thymic cortex. Proc. Natl. Acad. Sci. U.S.A. 105, 11903-11908. doi:10.1073/pnas.0801506105
145. Liu, W., Putnam, A. L., Xu-Yu, Z., Szot, G. L., Lee, M. R., Zhu, S., et al. (2006). CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells. J. Exp. Med. 203, 1701-1711. doi:10.1084/jem.20060772
146. Liu, Y., Zhang, P., Li, J., Kulkarni, A. B., Perruche, S., and Chen, W. (2008). A critical function for TGF-beta signaling in the development of natural CD4+CD25+Foxp3+ regulatory T cells. Nat. Immunol. 9, 632-640. doi:10.1038/ni.1607
147. Lodish, H. F., Zhou, B., Liu, G., and Chen, C.-Z. (2008). Micromanagement of the immune system by microRNAs. Nat. Rev. Immunol. 8, 120-130. doi:10.1038/nri2252
148. Lombardi, G., Sagoo, P., Scotta, C., Fazekasova, H., Smyth, L., Tsang, J., et al. (2011). Cell therapy to promote transplantation tolerance: a winning strategy? Immunotherapy 3, 28-31. doi:10.2217/imt.11.42
149. Long, M., Park, S.-G., Strickland, I., Hayden, M. S., and Ghosh, S. (2009). Nuclear factor-kappaB modulates regulatory T cell development by directly regulating expression of Foxp3 transcription factor. Immunity 31, 921-931. doi:10.1016/j.immuni.2009.09.022
150. Lu, L.-F., Boldin, M. P., Chaudhry, A., Lin, L.-L., Taganov, K. D., Hanada, T., et al. (2010). Function of miR-146a in controlling Treg cell-mediated regulation of Th1 responses. Cell 142, 914-929. doi:10.1016/j.cell.2010.08.012
151. Lu, L.-F., Thai, T.-H., Calado, D. P., Chaudhry, A., Kubo, M., Tanaka, K., et al. (2009). Foxp3-dependent MicroRNA155 confers competitive fitness to regulatory T cells by targeting SOCS1 protein. Immunity 30, 80-91. doi:10.1016/j.immuni.2008.11.010
152. Lykken, E. A., and Li, Q.-J. (2010). microRNAs at the regulatory frontier: an investigation into how microRNAs impact the development and effector functions of CD4 T cells. Immunol. Res. 49, 87-96. doi:10.1007/s12026-010-8196-4
153. Magnani, C. F., Alberigo, G., Bacchetta, R., Serafini, G., Andreani, M., Roncarolo, M. G., et al. (2011). Killing of myeloid APCs via HLA class I, CD2 and CD226 defines a novel mechanism of suppression by human Tr1 cells. Eur. J. Immunol. 41, 1652-1662. doi:10.1002/eji.201041120
154. Malek, T. R., Yu, A., Vincek, V., Scibelli, P., and Kong, L. (2002). CD4 regulatory T cells prevent lethal autoimmunity in IL-2Rbeta-deficient mice. Implications for the nonredundant function of IL-2. Immunity 17, 167-178. doi:10.1016/S1074-7613(02)00367-9
155. Maloy, K. J., Salaun, L., Cahill, R., Dougan, G., Saunders, N. J., and Powrie, F. (2003). CD4+CD25+ T(R) cells suppress innate immune pathology through cytokine-dependent mechanisms. J. Exp. Med. 197, 111-119. doi:10.1084/jem.20021345
156. Mandapathil, M., Szczepanski, M. J., Szajnik, M., Ren, J., Jackson, E. K., Johnson, J. T., et al. (2010). Adenosine and prostaglandin E2 cooperate in the suppression of immune responses mediated by adaptive regulatory T cells. J. Biol. Chem. 285, 27571-27580. doi:10.1074/jbc. M110.127100
157. Mangan, P. R., Harrington, L. E., O'Quinn, D. B., Helms, W. S., Bullard, D. C., Elson, C. O., et al. (2006). Transforming growth factor-beta induces development of the T(H)17 lineage. Nature 441, 231-234. doi:10.1038/nature04754
158. Mantel, P.-Y., Ouaked, N., Rückert, B., Karagiannidis, C., Welz, R., Blaser, K., et al. (2006). Molecular mechanisms underlying FOXP3 induction in human T cells. J. Immunol. 176, 3593-3602.
159. Marek-Trzonkowska, N., Mysliwiec, M. L., Dobyszuk, A., Grabowska, M., Techmanska, I., Juscinska, J., et al. (2012). Administration of CD4+ CD25highCD127-regulatory T cells preserves β-cell function in type 1 diabetes in children. Diabetes Care 35, 1817-1820. doi:10.2337/dc12-0038
160. Marie, J. C., Letterio, J. J., Gavin, M., and Rudensky, A. Y. (2005). TGF-beta1 maintains suppressor function and Foxp3 expression in CD4+CD25+ regulatory T cells. J. Exp. Med. 201, 1061-1067. doi:10.1084/jem.20042276
161. Marson, A., Kretschmer, K., Frampton, G. M., Jacobsen, E. S., Polansky, J. K., MacIsaac, K. D., et al. (2007). Foxp3 occupancy and regulation of key target genes during T-cell stimulation. Nature 445, 931-935. doi:10.1038/nature05478
162. Mayack, S. R., and Berg, L. J. (2006). Cutting edge: an alternative pathway of CD4+ T cell differentiation is induced following activation in the absence of gamma-chain-dependent cytokine signals. J. Immunol. 176, 2059-2063.
163. Maynard, C. L., Hatton, R. D., Helms, W. S., Oliver, J. R., Stephensen, C. B., and Weaver, C. T. (2009). Contrasting roles for all-trans retinoic acid in TGF-beta-mediated induction of Foxp3 and Il10 genes in developing regulatory T cells. J. Exp. Med. 206, 343-357. doi:10.1084/jem.20080950
164. Meiler, F., Zumkehr, J., Klunker, S., Rückert, B., Akdis, C. A., and Akdis, M. (2008). In vivo switch to IL-10-secreting T regulatory cells in high dose allergen exposure. J. Exp. Med. 205, 2887-2898. doi:10.1084/jem.20080193
165. Miyara, M., Yoshioka, Y., Kitoh, A., Shima, T., Wing, K., Niwa, A., et al. (2009). Functional delineation and differentiation dynamics of human CD4+ T cells expressing the FoxP3 transcription factor. Immunity 30, 899-911. doi:10.1016/j.immuni.2009.03.019
166. Morrissey, P. J., Charrier, K., Braddy, S., Liggitt, D., and Watson, J. D. (1993). CD4+ T cells that express high levels of CD45RB induce wasting disease when transferred into congenic severe combined immunodeficient mice. Disease development is prevented by cotransfer of purified CD4+ T cells. J. Exp. Med. 178, 237-244. doi:10.1084/jem.178.1.237
167. Mucida, D., Kutchukhidze, N., Erazo, A., Russo, M., Lafaille, J. J., and Curotto de Lafaille, M. A. (2005). Oral tolerance in the absence of naturally occurring Tregs. J. Clin. Invest. 115, 1923-1933. doi:10.1172/JCI24487
168. Mucida, D., Park, Y., Kim, G., Turovskaya, O., Scott, I., Kronenberg, M., et al. (2007). Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid. Science 317, 256-260. doi:10.1126/science.1145697
169. Muraro, P. A., Vergelli, M., Kalbus, M., Banks, D. E., Nagle, J. W., Tranquill, L. R., et al. (1997). Immunodominance of a low-affinity major histocompatibility complex-binding myelin basic protein epitope (residues 111-129) in HLA-DR4 (B10401) subjects is associated with a restricted T cell receptor repertoire. J. Clin. Invest. 100, 339-349. doi:10.1172/JCI119539
170. + T cells. Int. Immunol. 20, 1041-1055. doi:10.1093/intimm/dxn062
171. Nakamura, K., Kitani, A., and Strober, W. (2001). Cell contact-dependent immunosuppression by CD4(+)CD25(+) regulatory T cells is mediated by cell surface-bound transforming growth factor beta. J. Exp. Med. 194, 629-644. doi:10.1084/jem.194.5.629
172. Nakayamada, S., Takahashi, H., Kanno, Y., and O'Shea, J. J. (2012). Helper T cell diversity and plasticity. Curr. Opin. Immunol. 24, 297-302. doi:10.1016/j.coi.2012.01.014
173. Naranjo-Gómez, M., Raïch-Regué, D., Oñate, C., Grau-López, L., Ramo-Tello, C., Pujol-Borrell, R., et al. (2011). Comparative study of clinical grade human tolerogenic dendritic cells. J. Transl. Med. 9, 89. doi:10.1186/1479-5876-9-89
174. Ng, W. F., Duggan, P. J., Ponchel, F., Matarese, G., Lombardi, G., Edwards, A. D., et al. (2001). Human CD4(+)CD25(+) cells: a naturally occurring population of regulatory T cells. Blood 98, 2736-2744. doi:10.1182/blood. V98.9.2736
175. Nishizuka, Y., and Sakakura, T. (1969). Thymus and reproduction: sex-linked dysgenesia of the gonad after neonatal thymectomy in mice. Science 166, 753-755. doi:10.1126/science.166.3906.753
176. Ohkura, N., Hamaguchi, M., Morikawa, H., Sugimura, K., Tanaka, A., Ito, Y., et al. (2012). T cell receptor stimulation-induced epigenetic changes and Foxp3 expression are independent and complementary events required for Treg cell development. Immunity 37, 785-799. doi:10.1016/j.immuni.2012.09.010
177. Olson, B. M., Jankowska-Gan, E., Becker, J. T., Vignali, D. A. A., Burlingham, W. J., and McNeel, D. G. (2012). Human prostate tumor antigen-specific CD8+ regulatory T cells are inhibited by CTLA-4 or IL-35 blockade. J. Immunol. 189, 5590-5601. doi:10.4049/jimmunol.1201744
178. O'Shea, J. J., and Paul, W. E. (2010). Mechanisms underlying lineage commitment and plasticity of helper CD4+ T cells. Science 327, 1098-1102. doi:10.1126/science.1178334
179. Östman, S., Rask, C., Wold, A. E., Hultkrantz, S., and Telemo, E. (2006). Impaired regulatory T cell function in germ-free mice. Eur. J. Immunol. 36, 2336-2346. doi:10.1002/eji.200535244
180. Ouyang, W., Beckett, O., Ma, Q., Paik, J.-H., DePinho, R. A., and Li, M. O. (2010). Foxo proteins cooperatively control the differentiation of Foxp3+ regulatory T cells. Nat. Immunol. 11, 618-627. doi:10.1038/ni.1884
181. Paiva, R. S., Lino, A. C., Bergman, M.-L., Caramalho, I., Sousa, A. E., Zelenay, S., et al. (2013). Recent thymic emigrants are the preferential precursors of regulatory T cells differentiated in the periphery. Proc. Natl. Acad. Sci. U.S.A. 110, 6494-6499. doi:10.1073/pnas.1221955110
182. Pandiyan, P., Zheng, L., Ishihara, S., Reed, J., and Lenardo, M. J. (2007). CD4+CD25+Foxp3+ regulatory T cells induce cytokine deprivation-mediated apoptosis of effector CD4+ T cells. Nat. Immunol. 8, 1353-1362. doi:10.1038/ni1536
183. Papiernik, M., de Moraes, M. L., Pontoux, C., Vasseur, F., and Pénit, C. (1998). Regulatory CD4 T cells: expression of IL-2R alpha chain, resistance to clonal deletion and IL-2 dependency. Int. Immunol. 10, 371-378. doi:10.1093/intimm/10.4.371
184. Passerini, L., Di Nunzio, S., Gregori, S., Gambineri, E., Cecconi, M., Seidel, M. G., et al. (2011). Functional type 1 regulatory T cells develop regardless of FOXP3 mutations in patients with IPEX syndrome. Eur. J. Immunol. 41, 1120-1131. doi:10.1002/eji.201040909
185. Pennington, D. J., Silva-Santos, B., Silberzahn, T., Escórcio-Correia, M., Woodward, M. J., Roberts, S. J., et al. (2006). Early events in the thymus affect the balance of effector and regulatory T cells. Nature 444, 1073-1077. doi:10.1038/nature06051
186. Pesenacker, A. M., Bending, D., Ursu, S., Wu, Q., Nistala, K., and Wedderburn, L. R. (2013). CD161 defines the subset of FoxP3+ T cells capable of producing proinflammatory cytokines. Blood 121, 2647-2658. doi:10.1182/blood-2012-08-443473
187. Picca, C. C., and Caton, A. J. (2005). The role of self-peptides in the development of CD4+ CD25+ regulatory T cells. Curr. Opin. Immunol. 17, 131-136. doi:10.1016/j.coi.2005.01.003
188. Pillai, R. S., Bhattacharyya, S. N., and Filipowicz, W. (2007). Repression of protein synthesis by miRNAs: how many mechanisms? Trends Cell Biol. 17, 118-126. doi:10.1016/j.tcb.2006.12.007
189. Polansky, J. K., Kretschmer, K., Freyer, J., Floess, S., Garbe, A., Baron, U., et al. (2008). DNA methylation controls Foxp3 gene expression. Eur. J. Immunol. 38, 1654-1663. doi:10.1002/eji.200838105
190. Powrie, F., Carlino, J., Leach, M. W., Mauze, S., and Coffman, R. L. (1996). A critical role for transforming growth factor-beta but not interleukin 4 in the suppression of T helper type 1-mediated colitis by CD45RB(low) CD4+ T cells. J. Exp. Med. 183, 2669-2674. doi:10.1084/jem.183.6.2669
191. Puccetti, P., and Grohmann, U. (2007). IDO and regulatory T cells: a role for reverse signalling and non-canonical NF-kappaB activation. Nat. Rev. Immunol. 7, 817-823. doi:10.1038/nri2163
192. Read, S., Greenwald, R., Izcue, A., Robinson, N., Mandelbrot, D., Francisco, L., et al. (2006). Blockade of CTLA-4 on CD4+CD25+ regulatory T cells abrogates their function in vivo. J. Immunol. 177, 4376-4383.
193. Rengarajan, J., Mowen, K. A., McBride, K. D., Smith, E. D., Singh, H., and Glimcher, L. H. (2002). Interferon regulatory factor 4 (IRF4) interacts with NFATc2 to modulate interleukin 4 gene expression. J. Exp. Med. 195, 1003-1012. doi:10.1084/jem.20011128
194. Robertson, S. J., and Hasenkrug, K. J. (2006). The role of virus-induced regulatory T cells in immunopathology. Springer Semin. Immunopathol. 28, 51-62. doi:10.1007/s00281-006-0019-2
195. Romagnoli, P., Hudrisier, D., and van Meerwijk, J. P. M. (2002). Preferential recognition of self antigens despite normal thymic deletion of CD4(+)CD25(+) regulatory T cells. J. Immunol. 168, 1644-1648.
196. Rouas, R., Fayyadhyphen Kazan, H., Zein, E. N., Lewalle, P., Rotheacute, F. C. O., Simion, A., et al. (2009). Human natural Treg microRNA signature: role of microRNA & hyphen; 31 and microRNA & hyphen; 21 in FOXP3 expression. Eur. J. Immunol. 39, 1608-1618.
197. Roychoudhuri, R., Hirahara, K., Mousavi, K., Clever, D., Klebanoff, C. A., Bonelli, M., et al. (2013). BACH2 represses effector programs to stabilize Treg-mediated immune homeostasis. Nature doi:10.1038/nature12199. [Epub ahead of print].
198. Ruan, Q., Kameswaran, V., Tone, Y., Li, L., Liou, H.-C., Greene, M. I., et al. (2009). Development of Foxp3(+) regulatory t cells is driven by the c-Rel enhanceosome. Immunity 31, 932-940. doi:10.1016/j.immuni.2009.10.006
199. Rubtsov, Y. P., Niec, R. E., Josefowicz, S., Li, L., Darce, J., Mathis, D., et al. (2010). Stability of the regulatory T cell lineage in vivo. Science 329, 1667-1671. doi:10.1126/science.1191996
200. Russell, W. L., Russell, L. B., and Gower, J. S. (1959). Exceptional inheritance of a sex-linked gene in the mouse explained on the basis that the X/O sex-chromosome constitution is female. Proc. Natl. Acad. Sci. U.S.A. 45, 554-560. doi:10.1073/pnas.45.4.554
201. Sadlack, B., Merz, H., Schorle, H., Schimpl, A., Feller, A. C., and Horak, I. (1993). Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell 75, 253-261. doi:10.1016/0092-8674(93)80067-O
202. Safinia, N., Leech, J., Hernandez-Fuentes, M., Lechler, R., and Lombardi, G. (2013). Promoting transplantation tolerance; adoptive regulatory T cell therapy. Clin. Exp. Immunol. 172, 158-168. doi:10.1111/cei.12052
203. Sakaguchi, S. (2005). Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self. Nat. Immunol. 6, 345-352. doi:10.1038/ni1178
204. Sakaguchi, S., Sakaguchi, N., Asano, M., Itoh, M., and Toda, M. (1995). Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol. 155, 1151-1164.
205. Sakaguchi, S., Takahashi, T., and Nishizuka, Y. (1982). Study on cellular events in post-thymectomy autoimmune oophoritis in mice. II. Requirement of Lyt-1 cells in normal female mice for the prevention of oophoritis. J. Exp. Med. 156, 1577-1586. doi:10.1084/jem.156.6.1565
206. Sakaguchi, S., Toda, M., Asano, M., Itoh, M., Morse, S. S., and Sakaguchi, N. (1996). T cell-mediated maintenance of natural self-tolerance: its breakdown as a possible cause of various autoimmune diseases. J. Autoimmun. 9, 211-220. doi:10.1006/jaut.1996.0026
207. Sakaguchi, S., Wing, K., Onishi, Y., Prieto-Martin, P., and Yamaguchi, T. (2009). Regulatory T cells: how do they suppress immune responses? Int. Immunol. 21, 1105-1111. doi:10.1093/intimm/dxp095
208. Sakaguchi, S., Yamaguchi, T., Nomura, T., and Ono, M. (2008). Regulatory T cells and immune tolerance. Cell 133, 775-787. doi:10.1016/j.cell.2008.05.009
209. Salomon, B., Lenschow, D. J., Rhee, L., Ashourian, N., Singh, B., Sharpe, A., et al. (2000). B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes. Immunity 12, 431-440. doi:10.1016/S1074-7613(00)80195-8
210. Samon, J. B., Champhekar, A., Minter, L. M., Telfer, J. C., Miele, L., Fauq, A., et al. (2008). Notch1 and TGF 1 cooperatively regulate Foxp3 expression and the maintenance of peripheral regulatory T cells. Blood 112, 1813-1821. doi:10.1182/blood-2008-03-144980
211. Samstein, R. M., Arvey, A., Josefowicz, S. Z., Peng, X., Reynolds, A., Sandstrom, R., et al. (2012). Foxp3 exploits a pre-existent enhancer landscape for regulatory T cell lineage specification. Cell 151, 153-166. doi:10.1016/j.cell.2012.06.053
212. Sarris, M., Andersen, K. G., Randow, F., Mayr, L., and Betz, A. G. (2008). Neuropilin-1 expression on regulatory T cells enhances their interactions with dendritic cells during antigen recognition. Immunity 28, 402-413. doi:10.1016/j.immuni.2008.01.012
213. Sauer, S., Bruno, L., Hertweck, A., Finlay, D., Leleu, M., Spivakov, M., et al. (2008). T cell receptor signaling controls Foxp3 expression via PI3K, Akt, and mTOR. Proc. Natl. Acad. Sci. U.S.A. 105, 7797-7802. doi:10.1073/pnas.0800928105
214. Saurwein-Teissl, M., Lung, T. L., Marx, F., Gschösser, C., Asch, E., Blasko, I., et al. (2002). Lack of antibody production following immunization in old age: association with CD8(+)CD28(-) T cell clonal expansions and an imbalance in the production of Th1 and Th2 cytokines. J. Immunol. 168, 5893-5899.
215. Schmidt-Supprian, M., Courtois, G., Tian, J., Coyle, A. J., Israël, A., Rajewsky, K., et al. (2003). Mature T cells depend on signaling through the IKK complex. Immunity 19, 377-389. doi:10.1016/S1074-7613(03)00237-1
216. Schmidt-Supprian, M., Tian, J., Grant, E. P., Pasparakis, M., Maehr, R., Ovaa, H., et al. (2004). Differential dependence of CD4+CD25+ regulatory and natural killer-like T cells on signals leading to NF-kappaB activation. Proc. Natl. Acad. Sci. U.S.A. 101, 4566-4571. doi:10.1073/pnas.0400885101
217. Schubert, L. A., Jeffery, E., Zhang, Y., Ramsdell, F., and Ziegler, S. F. (2001). Scurfin (FOXP3) acts as a repressor of transcription and regulates T cell activation. J. Biol. Chem. 276, 37672-37679. doi:10.1074/jbc. M104521200
218. Schuster, M., Glauben, R., Plaza-Sirvent, C., Schreiber, L., Annemann, M., Floess, S., et al. (2012). IκB(NS) protein mediates regulatory T cell development via induction of the Foxp3 transcription factor. Immunity 37, 998-1008. doi:10.1016/j.immuni.2012.08.023
219. Scotta, C., Esposito, M., Fazekasova, H., Fanelli, G., Edozie, F. C., Ali, N., et al. (2012). Differential effects of rapamycin and retinoic acid on expansion, stability and suppressive qualities of human CD4+CD25+FOXP3+ Treg subpopulations. Haematologica doi:10.3324/haematol.2012.074088. [Epub ahead of print].
220. Scotto, L., Naiyer, A. J., Galluzzo, S., Rossi, P., Manavalan, J. S., Kim-Schulze, S., et al. (2004). Overlap between molecular markers expressed by naturally occurring CD4+CD25+ regulatory T cells and antigen specific CD4+CD25+ and CD8+CD28-T suppressor cells. Hum. Immunol. 65, 1297-1306. doi:10.1016/j.humimm.2004.09.004
221. Seder, R. A., Marth, T., Sieve, M. C., Strober, W., Letterio, J. J., Roberts, A. B., et al. (1998). Factors involved in the differentiation of TGF-beta-producing cells from naive CD4+ T cells: IL-4 and IFN-gamma have opposing effects, while TGF-beta positively regulates its own production. J. Immunol. 160, 5719-5728.
222. Selvaraj, R. K., and Geiger, T. L. (2007). A kinetic and dynamic analysis of Foxp3 induced in T cells by TGF-beta. J. Immunol. 178, 7667-7677.
223. Shevach, E. M. (2000). Regulatory T cells in autoimmmunity. Annu. Rev. Immunol. 18, 423-449. doi:10.1146/annurev.immunol.18.1.423
224. Shimizu, J., Yamazaki, S., and Sakaguchi, S. (1999). Induction of tumor immunity by removing CD25+CD4+ T cells: a common basis between tumor immunity and autoimmunity. J. Immunol. 163, 5211-5218.
225. Shimizu, J., Yamazaki, S., Takahashi, T., Ishida, Y., and Sakaguchi, S. (2002). Stimulation of CD25(+)CD4(+) regulatory T cells through GITR breaks immunological self-tolerance. Nat. Immunol. 3, 135-142. doi:10.1038/ni759
226. Shimo, Y., Yanai, H., Ohshima, D., Qin, J., Motegi, H., Maruyama, Y., et al. (2011). TRAF6 directs commitment to regulatory T cells in thymocytes. Genes Cells 16, 437-447. doi:10.1111/j.1365-2443.2011.01500.x
227. Siewert, C., Lauer, U., Cording, S., Bopp, T., Schmitt, E., Hamann, A., et al. (2008). Experience-driven development: effector/memory-like alphaE+Foxp3+ regulatory T cells originate from both naive T cells and naturally occurring naive-like regulatory T cells. J. Immunol. 180, 146-155.
228. Singer, A., Adoro, S., and Park, J.-H. (2008). Lineage fate and intense debate: myths, models and mechanisms of CD4-versus CD8-lineage choice. Nat. Rev. Immunol. 8, 788-801. doi:10.1038/nri2416
229. Strainic, M. G., Shevach, E. M., An, F., Lin, F., and Medof, M. E. (2012). Absence of signaling into CD4+ cells via C3aR and C5aR enables autoinductive TGF-β1 signaling and induction of Foxp3+ regulatory T cells. Nat. Immunol. 14, 162-171. doi:10.1038/ni.2499
230. Strauch, U. G., Obermeier, F., Grunwald, N., Gürster, S., Dunger, N., Schultz, M., et al. (2005). Influence of intestinal bacteria on induction of regulatory T cells: lessons from a transfer model of colitis. Gut 54, 1546-1552. doi:10.1136/gut.2004.059451
231. Sun, C.-M., Hall, J. A., Blank, R. B., Bouladoux, N., Oukka, M., Mora, J. R., et al. (2007). Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 T reg cells via retinoic acid. J. Exp. Med. 204, 1775-1785. doi:10.1084/jem.20070602
232. Suri-Payer, E., Amar, A. Z., Thornton, A. M., and Shevach, E. M. (1998). CD4+CD25+ T cells inhibit both the induction and effector function of autoreactive T cells and represent a unique lineage of immunoregulatory cells. J. Immunol. 160, 1212-1218.
233. Suzuki, H., Kündig, T. M., Furlonger, C., Wakeham, A., Timms, E., Matsuyama, T., et al. (1995). Deregulated T cell activation and autoimmunity in mice lacking interleukin-2 receptor beta. Science 268, 1472-1476. doi:10.1126/science.7770771
234. Szabo, S. J., Kim, S. T., Costa, G. L., Zhang, X., Fathman, C. G., and Glimcher, L. H. (2000). A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell 100, 655-669. doi:10.1016/S0092-8674(00)80702-3
235. Szabo, S. J., Sullivan, B. M., Stemmann, C., Satoskar, A. R., Sleckman, B. P., and Glimcher, L. H. (2002). Distinct effects of T-bet in TH1 lineage commitment and IFN-gamma production in CD4 and CD8 T cells. Science 295, 338-342. doi:10.1126/science.1065543
236. Taguchi, O., and Nishizuka, Y. (1981). Experimental autoimmune orchitis after neonatal thymectomy in the mouse. Clin. Exp. Immunol. 46, 425-434.
237. Tai, X., Cowan, M., Feigenbaum, L., and Singer, A. (2005). CD28 costimulation of developing thymocytes induces Foxp3 expression and regulatory T cell differentiation independently of interleukin 2. Nat. Immunol. 6, 152-162. doi:10.1038/ni1160
238. Takahashi, H., Kanno, T., Nakayamada, S., Hirahara, K., Sciumé, G., Muljo, S. A., et al. (2012). TGF-β and retinoic acid induce the microRNA miR-10a, which targets Bcl-6 and constrains the plasticity of helper T cells. Nat. Immunol. 13, 587-595. doi:10.1038/ni.2286
239. Takahashi, T., Kuniyasu, Y., Toda, M., Sakaguchi, N., Itoh, M., Iwata, M., et al. (1998). Immunologic self-tolerance maintained by CD25+CD4+ naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state. Int. Immunol. 10, 1969-1980. doi:10.1093/intimm/10.12.1969
240. Tang, Q., Bluestone, J. A., and Kang, S.-M. (2012). CD4(+)Foxp3(+) regulatory T cell therapy in transplantation. J. Mol. Cell Biol. 4, 11-21. doi:10.1093/jmcb/mjr047
241. Tang, Y., Luo, X., Cui, H., Ni, X., Yuan, M., Guo, Y., et al. (2009). MicroRNA-146A contributes to abnormal activation of the type I interferon pathway in human lupus by targeting the key signaling proteins. Arthritis Rheum. 60, 1065-1075. doi:10.1002/art.24436
242. Thornton, A. M., Korty, P. E., Tran, D. Q., Wohlfert, E. A., Murray, P. E., Belkaid, Y., et al. (2010). Expression of Helios, an Ikaros transcription factor family member, differentiates thymic-derived from peripherally induced Foxp3+ T regulatory cells. J. Immunol. 184, 3433-3441. doi:10.4049/jimmunol.0904028
243. Thornton, A. M., and Shevach, E. M. (1998). CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J. Exp. Med. 188, 287-296. doi:10.1084/jem.188.2.287
244. Tone, Y., Furuuchi, K., Kojima, Y., Tykocinski, M. L., Greene, M. I., and Tone, M. (2008). Smad3 and NFAT cooperate to induce Foxp3 expression through its enhancer. Nat. Immunol. 9, 194-202. doi:10.1038/ni1549
245. Tresoldi, E., Dell'Albani, I., Stabilini, A., Jofra, T., Valle, A., Gagliani, N., et al. (2011). Stability of human rapamycin-expanded CD4+CD25+ T regulatory cells. Haematologica 96, 1357-1365. doi:10.3324/haematol
246. Trzonkowski, P., Bieniaszewska, M., Juscinska, J., Dobyszuk, A., Krzystyniak, A., Marek, N., et al. (2009). First-in-man clinical results of the treatment of patients with graft versus host disease with human ex vivo expanded CD4+CD25+CD127-T regulatory cells. Clin. Immunol. 133, 22-26. doi:10.1016/j.clim
247. Veldhoen, M., Hocking, R. J., Atkins, C. J., Locksley, R. M., and Stockinger, B. (2006). TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 24, 179-189. doi:10.1016/j.immuni.2006.01.001
248. Venuprasad, K., Huang, H., Harada, Y., Elly, C., Subramaniam, M., Spelsberg, T., et al. (2008). The E3 ubiquitin ligase Itch regulates expression of transcription factor Foxp3 and airway inflammation by enhancing the function of transcription factor TIEG1. Nat. Immunol. 9, 245-253. doi:10.1038/ni1564
249. Vieira, P. L., Christensen, J. R., Minaee, S., O'Neill, E. J., Barrat, F. J., Boonstra, A., et al. (2004). IL-10-secreting regulatory T cells do not express Foxp3 but have comparable regulatory function to naturally occurring CD4+CD25+ regulatory T cells. J. Immunol. 172, 5986-5993.
250. Waldmann, H., Adams, E., Fairchild, P., and Cobbold, S. (2006). Infectious tolerance and the long-term acceptance of transplanted tissue. Immunol. Rev. 212, 301-313. doi:10.1111/j.0105-2896.2006.00406.x
251. Walker, M. R., Kasprowicz, D. J., Gersuk, V. H., Benard, A., van Landeghen, M., Buckner, J. H., et al. (2003). Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+CD25-T cells. J. Clin. Invest. 112, 1437-1443. doi:10.1172/JCI200319441
252. Wan, Y. Y., and Flavell, R. A. (2005). Identifying Foxp3-expressing suppressor T cells with a bicistronic reporter. Proc. Natl. Acad. Sci. U.S.A. 102, 5126-5131. doi:10.1073/pnas.0501701102
253. Wang, J., Ioan-Facsinay, A., van der Voort, E. I. H., Huizinga, T. W. J., and Toes, R. E. M. (2007). Transient expression of FOXP3 in human activated nonregulatory CD4+ T cells. Eur. J. Immunol. 37, 129-138. doi:10.1002/eji.200636435
254. Wei, G., Wei, L., Zhu, J., Zang, C., Hu-Li, J., Yao, Z., et al. (2009). Global mapping of H3K4me3 and H3K27me3 reveals specificity and plasticity in lineage fate determination of differentiating CD4+ T cells. Immunity 30, 155-167. doi:10.1016/j.immuni.2008.12.009
255. Wei, J., Duramad, O., Perng, O. A., Reiner, S. L., Liu, Y.-J., and Qin, F. X.-F. (2007). Antagonistic nature of T helper 1/2 developmental programs in opposing peripheral induction of Foxp3+ regulatory T cells. Proc. Natl. Acad. Sci. U.S.A. 104, 18169-18174. doi:10.1073/pnas.0703642104
256. Weiner, H. L. (2001). Induction and mechanism of action of transforming growth factorβ secreting Th3 regulatory cells. Immunol. Rev. 182, 207-214. doi:10.1034/j.1600-065X.2001.1820117.x
257. Weiss, J. M., Bilate, A. M., Gobert, M., Ding, Y., Curotto de Lafaille, M. A., Parkhurst, C. N., et al. (2012). Neuropilin 1 is expressed on thymus-derived natural regulatory T cells, but not mucosa-generated induced Foxp3+ T reg cells. J. Exp. Med. 209, 1723-1742. doi:10.1084/jem.20120914
258. Weng, N.-P., Akbar, A. N., and Goronzy, J. (2009). CD28-T cells: their role in the age-associated decline of immune function. Trends Immunol. 30, 306-312. doi:10.1016/j.it.2009.03.013
259. Wildin, R. S., Ramsdell, F., Peake, J., Faravelli, F., Casanova, J. L., Buist, N., et al. (2001). X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy. Nat. Genet. 27, 18-20. doi:10.1038/83707
260. Willerford, D. M., Chen, J., Ferry, J. A., Davidson, L., Ma, A., and Alt, F. W. (1995). Interleukin-2 receptor alpha chain regulates the size and content of the peripheral lymphoid compartment. Immunity 3, 521-530. doi:10.1016/1074-7613(95)90180-9
261. Willoughby, J. E., Costello, P. S., Nicolas, R. H., Robinson, N. J., Stamp, G., Powrie, F., et al. (2007). Raf signaling but not the ERK effector SAP-1 is required for regulatory T cell development. J. Immunol. 179, 6836-6844.
262. Wilson, C. B., Rowell, E., and Sekimata, M. (2009). Epigenetic control of T-helper-cell differentiation. Nat. Rev. Immunol. 9, 91-105. doi:10.1038/nri2487
263. Wing, K., Onishi, Y., Prieto-Martin, P., Yamaguchi, T., Miyara, M., Fehervari, Z., et al. (2008). CTLA-4 control over Foxp3+ regulatory T cell function. Science 322, 271-275. doi:10.1126/science.1160062
264. Wohlfert, E., and Belkaid, Y. (2008). Role of endogenous and induced regulatory T cells during infections. J. Clin. Immunol. 28, 707-715. doi:10.1007/s10875-008-9248-6
265. Wohlfert, E. A., Gorelik, L., Mittler, R., Flavell, R. A., and Clark, R. B. (2006). Cutting edge: deficiency in the E3 ubiquitin ligase Cbl-b results in a multifunctional defect in T cell TGF-beta sensitivity in vitro and in vivo. J. Immunol. 176, 1316-1320.
266. Wong, J., Mathis, D., and Benoist, C. (2007). TCR-based lineage tracing: no evidence for conversion of conventional into regulatory T cells in response to a natural self-antigen in pancreatic islets. J. Exp. Med. 204, 2039-2045. doi:10.1084/jem.20070822
267. Wood, K. J., and Sakaguchi, S. (2003). Regulatory T cells in transplantation tolerance. Nat. Rev. Immunol. 3, 199-210. doi:10.1038/nri1027
268. Xiao, S., Jin, H., Korn, T., Liu, S. M., Oukka, M., Lim, B., et al. (2008). Retinoic acid increases Foxp3+ regulatory T cells and inhibits development of Th17 cells by enhancing TGF-beta-driven Smad3 signaling and inhibiting IL-6 and IL-23 receptor expression. J. Immunol. 181, 2277-2284.
269. Xu, L., Kitani, A., Fuss, I., and Strober, W. (2007). Cutting edge: regulatory T cells induce CD4+CD25-Foxp3-T cells or are self-induced to become Th17 cells in the absence of exogenous TGF-beta. J. Immunol. 178, 6725-6729.
270. Xu, L., Kitani, A., Stuelten, C., McGrady, G., Fuss, I., and Strober, W. (2010). Positive and negative transcriptional regulation of the Foxp3 gene is mediated by access and binding of the Smad3 protein to enhancer I. Immunity 33, 313-325. doi:10.1016/j.immuni.2010.09.001
271. Yadav, M., Louvet, C., Davini, D., Gardner, J. M., Martínez-Llordella, M., Bailey-Bucktrout, S., et al. (2012). Neuropilin-1 distinguishes natural and inducible regulatory T cells among regulatory T cell subsets in vivo. J. Exp. Med. 209, 1713-1722. doi:10.1084/jem.20120822
272. Yamamoto, M., Kondo, E., Takeuchi, M., Harashima, A., Otani, T., Tsuji-Takayama, K., et al. (2011). miR-155, a Modulator of FOXO3a Protein Expression, Is Underexpressed and Cannot Be Upregulated by Stimulation of HOZOT, a Line of Multifunctional Treg. PLoS ONE 6:e16841. doi:10.1371/journal.pone.0016841
273. Yamazaki, S., Dudziak, D., Heidkamp, G. F., Fiorese, C., Bonito, A. J., Inaba, K., et al. (2008). CD8+ CD205+ splenic dendritic cells are specialized to induce Foxp3+ regulatory T cells. J. Immunol. 181, 6923-6933.
274. Yang, X. O., Nurieva, R., Martinez, G. J., Kang, H. S., Chung, Y., Pappu, B. P., et al. (2008). Molecular antagonism and plasticity of regulatory and inflammatory T cell programs. Immunity 29, 44-56. doi:10.1016/j.immuni.2008.05.007
275. Yao, Z., Kanno, Y., Kerenyi, M., Stephens, G., Durant, L., Watford, W. T., et al. (2007). Nonredundant roles for Stat5a/b in directly regulating Foxp3. Blood 109, 4368-4375. doi:10.1182/blood-2006-11-055756
276. Yi, R., Qin, Y., Macara, I. G., and Cullen, B. R. (2003). Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs. Genes Dev. 17, 3011-3016. doi:10.1101/gad.1158803
277. Yu, A., Zhu, L., Altman, N. H., and Malek, T. R. (2009). A low interleukin-2 receptor signaling threshold supports the development and homeostasis of T regulatory cells. Immunity 30, 204-217. doi:10.1016/j.immuni.2008.11.014
278. Zelenay, S., Bergman, M.-L., Paiva, R. S., Lino, A. C., Martins, A. C., Duarte, J. H., et al. (2010). Cutting edge: intrathymic differentiation of adaptive Foxp3+ regulatory T cells upon peripheral proinflammatory immunization. J. Immunol. 185, 3829-3833. doi:10.4049/jimmunol.1001281
279. Zheng, S. G., Wang, J., and Horwitz, D. A. (2008). Cutting edge: Foxp3+CD4+CD25+ regulatory T cells induced by IL-2 and TGF-beta are resistant to Th17 conversion by IL-6. J. Immunol. 180, 7112-7116.
280. Zheng, S. G., Wang, J. H., Stohl, W., Kim, K. S., Gray, J. D., and Horwitz, D. A. (2006). TGF-beta requires CTLA-4 early after T cell activation to induce FoxP3 and generate adaptive CD4+CD25+ regulatory cells. J. Immunol. 176, 3321-3329.
281. Zheng, W., and Flavell, R. A. (1997). The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T cells. Cell 89, 587-596. doi:10.1016/S0092-8674(00)80240-8
282. Zheng, Y., Chaudhry, A., Kas, A., DeRoos, P., Kim, J. M., Chu, T.-T., et al. (2009). Regulatory T-cell suppressor program co-opts transcription factor IRF4 to control T(H)2 responses. Nature 458, 351-356. doi:10.1038/nature07674
283. Zheng, Y., Josefowicz, S., Chaudhry, A., Peng, X. P., Forbush, K., and Rudensky, A. Y. (2010). Role of conserved non-coding DNA elements in the Foxp3 gene in regulatory T-cell fate. Nature 463, 808-812. doi:10.1038/nature08750
284. Zheng, Y., Josefowicz, S. Z., Kas, A., Chu, T.-T., Gavin, M. A., and Rudensky, A. Y. (2007). Genome-wide analysis of Foxp3 target genes in developing and mature regulatory T cells. Nature 445, 936-940. doi:10.1038/nature05563
285. Zhou, L., Chong, M. M. W., and Littman, D. R. (2009a). Plasticity of CD4+ T cell lineage differentiation. Immunity 30, 646-655. doi:10.1016/j.immuni.2009.05.001
286. Zhou, X., Bailey-Bucktrout, S. L., Jeker, L. T., Penaranda, C., Martínez-Llordella, M., Ashby, M., et al. (2009b). Instability of the transcription factor Foxp3 leads to the generation of pathogenic memory T cells in vivo. Nat. Immunol. 10, 1000-1007. doi:10.1038/ni.1774
287. Zhou, L., Lopes, J. E., Chong, M. M. W., Ivanov, I. I., Min, R., Victora, G. D., et al. (2008a). TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgammat function. Nature 453, 236-240. doi:10.1038/nature06878
288. Zhou, X., Jeker, L. T., Fife, B. T., Zhu, S., Anderson, M. S., McManus, M. T., et al. (2008b). Selective miRNA disruption in T reg cells leads to uncontrolled autoimmunity. J. Exp. Med. 205, 1983-1991. doi:10.1084/jem.20080707
289. Zhu, J., Yamane, H., and Paul, W. E. (2010). Differentiation of effector CD4 T cell populations(*). Annu. Rev. Immunol. 28, 445-489. doi:10.1146/annurev-immunol-030409-101212
290. Ziegler, S. F. (2006). FOXP3: of mice and men. Annu. Rev. Immunol. 24, 209-226. doi:10.1146/annurev.immunol.24.021605.090547
291. Zorn, E., Nelson, E. A., Mohseni, M., Porcheray, F., Kim, H., Litsa, D., et al. (2006). IL-2 regulates FOXP3 expression in human CD4+CD25+ regulatory T cells through a STAT-dependent mechanism and induces the expansion of these cells in vivo. Blood 108, 1571-1579. doi:10.1182/blood-2006-02-004747
292. Zou, W. (2006). Regulatory T cells, tumour immunity and immunotherapy. Nat. Rev. Immunol. 6, 295-307. doi:10.1038/nri1806